SCHEMBL5708289

SCHEMBL5708289

COC(=O)C(NC(=O)N(C)Cc1csc(CC(C)=O)n1)C(C)C

nearest known ligand 0.44

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 18/20 0.44
CYP2D6 P10635 5/20 0.42
CYP2C19 P33261 4/20 0.42
CYP2C9 P11712 4/20 0.42
RAB9A P51151 1/20 0.40
CYP1A2 P05177 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7091733 0.89 CYP3A4 (0.45) CYP3A4CYP2D6CYP2C19CYP2C9CYP1A2
SCHEMBL7183478 0.88 CYP3A4 (0.47) CYP3A4CYP2D6CYP2C19CYP2C9RAB9A
SCHEMBL7178760 0.88 CYP3A4 (0.44) CYP3A4CYP2D6CYP2C19CYP2C9CYP1A2
SCHEMBL6426461 0.86 CYP3A4 (0.43) CYP3A4CYP2D6CYP2C19CYP2C9CYP1A2
SCHEMBL2736273 0.84 CYP3A4 (0.51) CYP3A4CYP2D6CYP2C19CYP2C9CYP1A2
SCHEMBL7301480 0.84 CYP3A4 (0.51) CYP3A4CYP2D6CYP2C19CYP2C9CYP1A2
SCHEMBL7179423 0.83 CYP3A4 (0.48) CYP3A4CYP2D6CYP2C19CYP2C9CYP1A2
SCHEMBL18531996 0.83 CYP3A4 (0.59) CYP3A4CYP2D6CYP2C19CYP2C9CYP1A2
SCHEMBL2736207 0.83 CYP3A4 (0.59) CYP3A4CYP2D6CYP2C19CYP2C9CYP1A2
SCHEMBL7301247 0.83 CYP3A4 (0.46) CYP3A4CYP2D6CYP2C19CYP2C9CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1711617-A1 METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTICS COMPOUNDS GILEAD SCIENCES, INC. (US) 2006-10-18 EP disclosed
WO-2005064008-A9 METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTIC COMPOUNDS GILEAD SCIENCES INC (US) 2006-09-28 WO disclosed
WO-2005064008-A1 METHOD AND COMPOSITIONS FOR IDENTIFYING ANTI-HIV THERAPEUTIC COMPOUNDS GILEAD SCIENCES, INC. (US) 2005-07-14 WO disclosed